These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38443105)

  • 21. Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.
    Umapathysivam MM; Lee MY; Jones KL; Annink CE; Cousins CE; Trahair LG; Rayner CK; Chapman MJ; Nauck MA; Horowitz M; Deane AM
    Diabetes; 2014 Feb; 63(2):785-90. PubMed ID: 24089511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. User's guide to mechanism of action and clinical use of GLP-1 receptor agonists.
    Shaefer CF; Kushner P; Aguilar R
    Postgrad Med; 2015; 127(8):818-26. PubMed ID: 26371721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into the effects of diabetes on gastric motility.
    Marathe CS; Rayner CK; Jones KL; Horowitz M
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):581-93. PubMed ID: 26647088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.
    Smith K; Taylor GS; Allerton DM; Brunsgaard LH; Bowden Davies KA; Stevenson EJ; West DJ
    Front Endocrinol (Lausanne); 2021; 12():696977. PubMed ID: 34220720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.
    Vergès B; Bonnard C; Renard E
    Diabetes Metab; 2011 Dec; 37(6):477-88. PubMed ID: 21871831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of anti-diabetic therapy based on glucagon-like peptide-1 receptor agonists on the cardiovascular risk of patients with type 2 diabetes mellitus].
    Camafort-Babkowski M
    Med Clin (Barc); 2013 Aug; 141(4):167-74. PubMed ID: 23332622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults.
    van Can J; Sloth B; Jensen CB; Flint A; Blaak EE; Saris WH
    Int J Obes (Lond); 2014 Jun; 38(6):784-93. PubMed ID: 23999198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes mellitus and gastric emptying: questions and issues in clinical practice.
    Samsom M; Bharucha A; Gerich JE; Herrmann K; Limmer J; Linke R; Maggs D; Schirra J; Vella A; Wörle HJ; Göke B
    Diabetes Metab Res Rev; 2009 Sep; 25(6):502-14. PubMed ID: 19610128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can GLP-1 preparations be used in children and adolescents with diabetes mellitus?
    Shehadeh N; Daich E; Zuckerman-Levin N
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):324-7. PubMed ID: 24716398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Imaging of Evaluation of Diabetic Gastroparesis.
    Santhanam P; Marashdeh W; Solnes L
    Curr Diabetes Rev; 2018; 14(3):222-226. PubMed ID: 28128051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
    Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus.
    Owens DR; Monnier L; Bolli GB
    Diabetes Metab; 2013 Dec; 39(6):485-96. PubMed ID: 24156868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?
    Asmar M; Bache M; Knop FK; Madsbad S; Holst JJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2367-75. PubMed ID: 20194711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
    Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA
    J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic gastroparesis and its impact on glycemia.
    Chang J; Rayner CK; Jones KL; Horowitz M
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):745-62. PubMed ID: 21095542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.
    Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2719-25. PubMed ID: 12788879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.
    Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI
    Eur J Clin Nutr; 2003 Feb; 57(2):293-8. PubMed ID: 12571662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1.
    Wishart JM; Horowitz M; Morris HA; Jones KL; Nauck MA
    Peptides; 1998; 19(6):1049-53. PubMed ID: 9700754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
    McCallum RW; Cynshi O;
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.